APCRA_Helsinki_F2F_Bioactivity_case_study_Oct2017_v6.pdf (1.32 MB)
Examining the Utility of In Vitro Bioactivity as a Conservative Point of Departure: A Case Study
presentation
posted on 2018-06-28, 13:37 authored by Katie Paul-FriedmanPresentation for the Advancing the Pace of Chemical Risk Assessment (APCRA) Meeting October 2017